To Give or Not to Give Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal Cancer

被引：1
作者：
Kim, Richard [1 ]
Kubal, Timothy [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Oncol, Tampa, FL 33682 USA
来源：
CLINICAL COLORECTAL CANCER | 2012年 / 11卷 / 02期
关键词：
1ST-LINE TREATMENT; CETUXIMAB; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN;
D O I：
10.1016/j.clcc.2011.10.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 87
页数：3
相关论文
共 19 条
  • [1] American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
    Allegra, Carmen J.
    Jessup, J. Milburn
    Somerfield, Mark R.
    Hamilton, Stanley R.
    Hammond, Elizabeth H.
    Hayes, Daniel F.
    McAllister, Pamela K.
    Morton, Roscoe F.
    Schilsky, Richard L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2091 - 2096
  • [2] [Anonymous], J CLIN ONCOL S
  • [3] Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
    Bokemeyer, Carsten
    Bondarenko, Igor
    Makhson, Anatoly
    Hartmann, Joerg T.
    Aparicio, Jorge
    de Braud, Filippo
    Donea, Serban
    Ludwig, Heinz
    Schuch, Gunter
    Stroh, Christopher
    Loos, Anja H.
    Zubel, Angela
    Koralewski, Piotr
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 663 - 671
  • [4] Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
    De Roock, Wendy
    Jonker, Derek J.
    Di Nicolantonio, Federica
    Sartore-Bianchi, Andrea
    Tu, Dongsheng
    Siena, Salvatore
    Lamba, Simona
    Arena, Sabrina
    Frattini, Milo
    Piessevaux, Hubert
    Van Cutsem, Eric
    O'Callaghan, Chris J.
    Khambata-Ford, Shirin
    Zalcberg, John R.
    Simes, John
    Karapetis, Christos S.
    Bardelli, Alberto
    Tejpar, Sabine
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (16): : 1812 - 1820
  • [5] Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
    Di Nicolantonio, Federica
    Arena, Sabrina
    Gallicchio, Margherita
    Zecchin, Davide
    Martini, Miriam
    Flonta, Simona Emilia
    Stella, Giulia Maria
    Lamba, Simona
    Cancelliere, Carlotta
    Russo, Mariangela
    Geuna, Massimo
    Appendino, Giovanni
    Fantozzi, Roberto
    Medico, Enzo
    Bardelli, Alberto
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) : 20864 - 20869
  • [6] Finkelstein S. D., 1993, ARCH SURG-CHICAGO, V128, P531
  • [7] FINKELSTEIN SD, 1993, ARCH SURG-CHICAGO, V128, P526
  • [8] FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO
  • [9] 2-N
  • [10] Guerrero S, 2000, CANCER RES, V60, P6750
12